| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/04/2004 | EP0865487B1 Preparation of a multicombinatorial library of antibody gene expression vectors |
| 08/04/2004 | EP0764171B1 Ligands for induction of antigen specific apoptosis in t cells |
| 08/04/2004 | EP0725829B1 Methods and compositions for high protein production from recombinant dna |
| 08/04/2004 | EP0637963B1 Cd28 pathway immunoregulation |
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1518459A Remedies for eosinophilic diseases |
| 08/04/2004 | CN1518458A Graft rejection inhibitors |
| 08/04/2004 | CN1517436A Oxide-reductase |
| 08/04/2004 | CN1517362A New Polypeptide-human ribosome protein s9 containing ATP/GTP conjugated structure domain and polynucleotide coding said polypetide |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/04/2004 | CN1160369C Preparation of anti cytoplasmic thymidine kinase-IgY antibody and tumor diagnosis composition |
| 08/04/2004 | CN1160126C Immunoadsorber for use in sepsis therapy |
| 08/04/2004 | CN1160119C Functions for Tob gene in central nervous system of mammol and its application |
| 08/03/2004 | US6770745 Common gamma chain blocking agents |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770742 Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770467 Screening method for ligands with class II P13 kinase modulating activity |
| 08/03/2004 | US6770466 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770455 Preparation, use and medicaments containing ribonucleotide polypeptides or their molecular-biological equivalent structures and/or parts and/or derivatives |
| 08/03/2004 | US6770450 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 08/03/2004 | US6770438 Oncogene, oncoprotein; associated with tumorigenicity; mn genes from cellular component of matu, a quasi viral agent derived from a human mammary tumor |
| 08/03/2004 | US6770281 B-cell epitope peptides of HSP 65 |
| 08/03/2004 | US6770280 Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product |
| 08/03/2004 | US6770278 To treat exercise induced pulmonary hemorrhage in horses |
| 08/03/2004 | US6770277 Recombinant DNase B derived from streptococcus pyogenes |
| 08/03/2004 | US6770272 Treatment of diabetes |
| 08/03/2004 | CA2142599C Method for diagnosing and monitoring sepsis |
| 07/29/2004 | WO2004063751A1 Opctical fiber array device capable of simultaneously performing multiple functional assays |
| 07/29/2004 | WO2004063750A1 Method of evaluating hair growth-promoting activity |
| 07/29/2004 | WO2004063355A2 Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer |
| 07/29/2004 | WO2004063351A2 IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME |
| 07/29/2004 | WO2004063347A2 Epad, an oocyte specific protein |
| 07/29/2004 | WO2004063343A2 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 07/29/2004 | WO2004063335A2 TNF-α BINDING MOLECULES |
| 07/29/2004 | WO2004063214A2 Antibodies that specifically recognize sumo-conjugated proteins |
| 07/29/2004 | WO2004062684A2 Treatment of thrombocytopenia with inhibitors of pacap |
| 07/29/2004 | WO2004062619A2 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 07/29/2004 | WO2004062602A2 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | WO2004062578A2 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | WO2004062551A2 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 07/29/2004 | WO2004062462A2 Monclonal anitbodies to rna binding protein gw182 |
| 07/29/2004 | WO2004048413A3 Cd55-interaction partners and the uses thereof |
| 07/29/2004 | WO2004046191A3 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 07/29/2004 | WO2004045379A3 Biomarkers for intra-amniotic inflammation |
| 07/29/2004 | WO2004044156A3 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 07/29/2004 | WO2004044001A3 Acetylated hmgb1 protein |
| 07/29/2004 | WO2004041297A3 Modified cytokines for use in cancer therapy |
| 07/29/2004 | WO2004039963A8 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof |
| 07/29/2004 | WO2004031238A3 Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics |
| 07/29/2004 | WO2004029069A3 Hybridomas producing high levels of human sequence antibody |
| 07/29/2004 | WO2004024889A3 Production of bispecific molecules using polyethylene glycol linkers |
| 07/29/2004 | WO2004024746A3 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2003103481A3 Methods for detecting b. anthracis infection |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003093313A3 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003068920A8 Humanized gm-csf antibodies |
| 07/29/2004 | WO2003068915A3 Production of human antibodies in immunodeficient, non-human, mammalian hosts |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003033644A3 Peptide useful in immunomodulation |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | US20040148646 Animals comprising human hepatocellular tissue |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147727 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147474 For use as vaccines against bacterial infections, diagnosis, prophylactic and therapeutic uses. |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147447 For therapy of cancer or autoimmune diseases |
| 07/29/2004 | US20040147440 Compositions comprising cell-impermeant duramycin derivatives |
| 07/29/2004 | US20040147044 Antigens |
| 07/29/2004 | US20040147025 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146991 Identifying modulator of activation inducible lymphocyte immunomodulatory molecule (AILIM) for use in suppressing, preventing and/or treating inflammatory, autoimmune and allergic disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146989 Nucleotide sequences coding cytokine fusion protein for use in the prevention and treatment of tumor and viral infections |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146948 single-chain variable region fragment (scFv) comprising a heavy chain variable region (VH) operably linked to a light chain variable region (VL); for cancer treatment |
| 07/29/2004 | US20040146947 Inflammatory bowel disease: noninvasive diagnosis |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146934 Multi-functional antibodies |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146896 Methods and compositions for diagnosing and treating companion animal cancer |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146857 Immunoglobulin for detection, prevention, treatment and prognosis of viral infections |
| 07/29/2004 | US20040146854 Attenuated forms of bovine viral diarrhea virus |
| 07/29/2004 | US20040146532 Agents and methods for treating pain |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |